Skip to main content
. 2019 Apr 15;14(4):e0215093. doi: 10.1371/journal.pone.0215093

Table 2. A. IRE treatment parameters of the presented patient cohort.

B. Ablation field extent. C. Procedure categories of patients with more than one IRE application.

    A. IRE Parameters
Total number of procedures 471
Total number of patients 429
Mean number of electrodes used 5 ± 1
Mean procedure time 120 ± 34 min
Mean set voltage-to-distance-ratio 1518.13 ± 204.05 V/cm
Mean ablated ablated /%* 72.4 ± 25.9%
    B. Treatment Extent
Uni-lobar or focal (≤50%) 123
Bi-lobar but not whole gland
(>50% and ≤90%)
153
Whole gland (>90%) 134
Cannot be determined or recurrence 63
    C. Re-treatments categorized
Sum of re-treatments 43
Tumor extent/prostate-size related 8
Incomplete ablation/tumor residue 3
In-field recurrence 12
Out-of-field recurrence 16
Extra prostatic cancer (i.e. seminal vesicles) 3

*according to MRI evaluation 24h post IRE.